Minnesota aligns drug pricing with federal Medicare program

File HF5156 ("Minnesota aligns drug pricing with federal Medicare program") is before the Minnesota Legislature and has not been decided. Latest step (May 17, 2026): Introduction and first reading, referred to.

Minnesota file HF5156, before the Minnesota Legislature. Still to be decided as of 2026-05-17.

What it does

Your prescription costs may fall if negotiated prices apply If Minnesota enrolls in or mirrors the federal Medicare Drug Price Negotiation Program, seniors and some disabled residents could pay lower out-of-pocket costs for high-cost drugs, though the magnitude depends on which drugs are selected for negotiation and your specific plan.

The bigger picture

Pharma pricing leverage shifts toward state and federal programs State alignment with federal negotiation rules could expand the pool of negotiated drugs available in Minnesota plans and reduce leverage for pharmaceutical manufacturers, potentially affecting drug availability timelines and innovation pipelines statewide.

What to watch

Drug makers may restrict access or raise prices elsewhere Pharmaceutical manufacturers could respond to negotiated-price requirements by limiting distribution to Minnesota, delaying new drug launches, or raising prices in non-negotiated markets to offset revenue loss.

Official summary

Price for prescription drugs subject to the Medicare Drug Price Negotiation Program established.

Read the official record for HF5156

See everything up for a vote · This week in Minnesota · See what we have filed with the clerk